(1 - 7 von 10
)
Neuralstem Chief Scientific Officer To Present At Spinal Cord Injury...
www.finanznachrichten.de
ROCKVILLE, Md., April 25, PRNewswire/ --Neuralstem, Inc. (NYSE Amex: CUR) announced that Karl Johe, PhD, Chairman and Chief Scientific Officer, will present at ...
Zellen von Neuralstem Inc. überleben und werden zu Neuronen bei ...
www.bionity.com
"Vom Rückenmark wurde bislang angenommen, dass es für neuronale Stammzelltransplantate feindlich sei", kommentierte Dr. Karl Johe, wissenschaftlicher Gründer und Chairman von Neuralstem und ein Koautor der Studie ...
One moment, please...
www.disabled-world.com
Karl Johe, PhD, Neuralstem's Chairman and Chief Scientific Officer, explained the scientific rationale behind the Neuralstem therapy.
Next events - German Biotech Database
www.germanbiotech.com
... in Phase I, which was through direct injections into the gray matter of the spinal cord," said Karl Johe, PhD, Neuralstem Chairman and Chief Scientific Officer.
sortiert nach Relevanz / Datum